Premium
P3‐093: Characterization of CSF Aβ 1–42 , Tau and p‐Tau 181p concentrations at baseline in Alzheimer's disease neuroimaging initiative study patients
Author(s) -
Shaw Leslie M.,
Vanderstichele Hugo,
Knapik-Czajka Malgorzata,
Blennow Kaj,
Soares Holly,
Simon Adam,
Lewczuk Piotr,
Siemers Eric,
Dean Robert,
Potter William Z.,
Lee Virginia M.-Y.,
Trojanowski John Q.
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.1657
Subject(s) - alzheimer's disease neuroimaging initiative , biomarker , neuroimaging , neuropsychology , medicine , oncology , cognitive impairment , clinical trial , mann–whitney u test , alzheimer's disease , neuropsychological assessment , disease , cognition , psychiatry , biochemistry , chemistry